rs397516572
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BP6BS2
The NM_001103.4(ACTN2):c.2003C>G(p.Thr668Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,614,106 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T668T) has been classified as Likely benign.
Frequency
Consequence
NM_001103.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTN2 | NM_001103.4 | c.2003C>G | p.Thr668Arg | missense_variant | Exon 17 of 21 | ENST00000366578.6 | NP_001094.1 | |
ACTN2 | NM_001278343.2 | c.2003C>G | p.Thr668Arg | missense_variant | Exon 17 of 21 | NP_001265272.1 | ||
ACTN2 | NR_184402.1 | n.2375C>G | non_coding_transcript_exon_variant | Exon 19 of 23 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152214Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000517 AC: 13AN: 251474Hom.: 0 AF XY: 0.0000441 AC XY: 6AN XY: 135910
GnomAD4 exome AF: 0.0000458 AC: 67AN: 1461892Hom.: 0 Cov.: 32 AF XY: 0.0000330 AC XY: 24AN XY: 727248
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152214Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Thr668Arg variant in ACTN2 (ClinVar variation ID 43922) has been identified by our laboratory in one adult with DCM and 1 an infant with LVNC, both of whom also carried variants of unknown significance in other genes, and one Caucasian adult with HCM whom carried a known pathogenic variant in an HCM associated gene (LMM unpublished data, Walsh 2017). It has been identified in 0.01% (12/113748) of European chromosomes by gnomAD (http://gnomad.broadinstitute.org). Given the rarity of pathogenic ACTN2 variants, this frequency suggests that this variant may not be highly penetrant or may be benign. Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: none. -
Intrinsic cardiomyopathy Uncertain:1
- -
not provided Uncertain:1
Reported in association with DCM and LVNC in published literature and in individuals referred for genetic testing at GeneDx; however, detailed clinical information was not provided and/or additional cardiogenetic variants were also identified (Pugh et al., 2014; Walsh et al., 2017; Mazzarotto et al., 2021); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 24503780, 33500567, 27532257) -
Primary familial hypertrophic cardiomyopathy;C2677338:Dilated cardiomyopathy 1AA Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at